Oncology Brothers: 6 new drugs in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA
Oncology Brothers shared a post on X:
“2024 approvals: Summary of 6 new drugs/indications in Skin Cancer, Thyroid Cancer, Sarcoma and Glioma by U.S. FDA.
1. Lifileucel
2. Selpercatinib
3. AfamiCel
4. Vorasidenib
5. Cosibelimab
Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families. Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.
More posts from Oncology Brothers.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023